Suppr超能文献

人体血浆中的α-生育酚立体异构体受所使用的维生素E补充剂的水平和形式影响。

α-Tocopherol Stereoisomers in Human Plasma Are Affected by the Level and Form of the Vitamin E Supplement Used.

作者信息

Zhao Yang, Monahan Frank J, McNulty Breige A, Brennan Lorraine, Gibney Mike J, Gibney Eileen R

机构信息

UCD Institute of Food and Health, University College Dublin, Dublin, Ireland.

UCD Institute of Food and Health, University College Dublin, Dublin, Ireland

出版信息

J Nutr. 2015 Oct;145(10):2347-54. doi: 10.3945/jn.115.213280. Epub 2015 Aug 19.

Abstract

BACKGROUND

Studies examining vitamin E intake and the percentage of the population meeting dietary guidelines do not distinguish between natural (RRR-α-tocopherol) and synthetic (all-rac-α-tocopherol) intake, even though these different isomeric forms differ in bioactivity.

OBJECTIVE

This study aimed to determine the effect of RRR-α-tocopherol vs. all-rac-α-tocopherol intake on the percentage of the population meeting the vitamin E recommendation and on plasma α-tocopherol stereoisomer distribution.

METHODS

With the use of data from the Irish National Adult Nutrition Survey (NANS), this study examined the percentage of the Irish population meeting the European Union (EU) RDA for vitamin E of 12 mg/d, correcting for a bioactivity difference in all-rac- vs. RRR-α-tocopherol, where 1 mg of all-rac-α-tocopherol is considered to be equivalent to 1:1.36 (0.74) mg in the EU RDA. In a subcohort of supplement users and nonusers, plasma α- and γ-tocopherol concentrations and α-tocopherol stereoisomer distribution were measured. Receiver operating characteristic (ROC) curve analysis was conducted to determine ability to discriminate supplement user types.

RESULTS

Analysis of the NANS showed that 100% of participants still met the recommended intake of 12 mg/d, after all-rac-α-tocopherol intake was corrected for α-tocopherol equivalent bioactivity. In the subcohort analysis, the percentage of plasma RRR-α-tocopherol was significantly lower in high all-rac-α-tocopherol supplement (>11 mg/d) users (82%) compared with nonusers and with high RRR-α-tocopherol supplement (>35 mg/d) users (91% and 93% respectively, P < 0.01). High RRR-α-tocopherol supplement users had a significantly higher plasma α-tocopherol than low all-rac-α-tocopherol supplement (<2.5 mg/d) users (34 vs. 25 μmol/L, P = 0.01). ROC analysis demonstrated an ability to distinguish between RRR- and all-rac-α-tocopherol consumers, which may be useful in investigating the potential effect of RRR- and all-rac-α-tocopherol intake on health.

CONCLUSIONS

This study demonstrated that the percentage of the population meeting the vitamin E recommendation was unaffected when all-rac-α-tocopherol intake was corrected for α-tocopherol equivalent bioactivity. all-rac-α-Tocopherol intake led to a decrease in the percentage of plasma RRR-α-tocopherol relative to RRR-α-tocopherol intake.

摘要

背景

尽管天然(RRR-α-生育酚)和合成(消旋-α-生育酚)形式的维生素E生物活性不同,但研究维生素E摄入量及达到膳食指南要求的人群比例时,并未区分这两种形式的摄入量。

目的

本研究旨在确定RRR-α-生育酚与消旋-α-生育酚的摄入量对达到维生素E推荐量的人群比例以及血浆α-生育酚立体异构体分布的影响。

方法

利用爱尔兰国家成人营养调查(NANS)的数据,本研究考察了爱尔兰人群中达到欧盟(EU)维生素E推荐膳食摄入量(RDA)12毫克/天的比例,并根据消旋-α-生育酚与RRR-α-生育酚的生物活性差异进行校正,在欧盟RDA中,1毫克消旋-α-生育酚相当于1:1.36(0.74)毫克RRR-α-生育酚。在补充剂使用者和非使用者的一个亚组中,测量血浆α-和γ-生育酚浓度以及α-生育酚立体异构体分布。进行受试者工作特征(ROC)曲线分析以确定区分补充剂使用者类型 的能力。

结果

对NANS的分析表明,在校正消旋-α-生育酚的α-生育酚等效生物活性后,100%的参与者仍达到12毫克/天的推荐摄入量。在亚组分析中,高剂量消旋-α-生育酚补充剂(>11毫克/天)使用者血浆中RRR-α-生育酚的比例(82%)显著低于非使用者以及高剂量RRR-α-生育酚补充剂(>35毫克/天)使用者(分别为91%和93%,P<0.01)。高剂量RRR-α-生育酚补充剂使用者的血浆α-生育酚水平显著高于低剂量消旋-α-生育酚补充剂(<2.5毫克/天)使用者(34对25微摩尔/升,P = 0.01)。ROC分析表明能够区分RRR-和消旋-α-生育酚消费者,这可能有助于研究RRR-和消旋-α-生育酚摄入量对健康的潜在影响。

结论

本研究表明,在校正消旋-α-生育酚的α-生育酚等效生物活性后,达到维生素E推荐量的人群比例未受影响。与RRR-α-生育酚摄入量相比,消旋-α-生育酚摄入量导致血浆RRR-α-生育酚比例下降。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验